Programme

Short communications A2

Monday 22 May 2017
13:30-15:00
Stockholmsmässan : K2

Chair: Michael Sorich / Australia
Co-chair: Nebojsa Mihajlica / Sweden 

 

1

Optimization of drug delivery to tissues and avoiding drug induced phospholipidosis

 

Irena Loryan

Sweden, Germany, Netherlands

2

Evaluation of DILI predictive hypotheses in early drug development

 

Rosa Chan

USA

3

Magnetically bioprinted three dimensional scaffold-free liver model for nanotoxicity studies

 

Iqbal Ramzan

Australia

4

A comparison of two different self immolative linker strategies in the design of lymph directing, triglyceride mimetic prodrugs of buprenorphine

 

Sifei Han

Australia

5

Revealing multiple biochemical response patterns of remoxipride by integrating pharmacometabolomics and pharmacokinetic/pharmacodynamic modeling

 

Willem van den Brink

Netherlands, UK

6

Development of a novel method to estimate chronological changes of long-term progression of chronic diseases

 

Masashi Honma

Japan